Goldman Sachs’s Tectonic Therapeutic, Inc. Common Stock TECX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-104,793
| Closed | -$1.86M | – | 5414 |
|
2025
Q1 | $1.86M | Buy |
104,793
+80,483
| +331% | +$1.43M | ﹤0.01% | 3408 |
|
2024
Q4 | $1.12M | Buy |
+24,310
| New | +$1.12M | ﹤0.01% | 3850 |
|
2023
Q1 | – | Sell |
-840
| Closed | -$7.19K | – | 5288 |
|
2022
Q4 | $7.19K | Sell |
840
-58,063
| -99% | -$497K | ﹤0.01% | 4971 |
|
2022
Q3 | $454K | Buy |
58,903
+46,532
| +376% | +$359K | ﹤0.01% | 4306 |
|
2022
Q2 | $136K | Sell |
12,371
-10,275
| -45% | -$113K | ﹤0.01% | 5020 |
|
2022
Q1 | $359K | Sell |
22,646
-92,501
| -80% | -$1.47M | ﹤0.01% | 4781 |
|
2021
Q4 | $5.32M | Buy |
115,147
+79,135
| +220% | +$3.66M | ﹤0.01% | 2752 |
|
2021
Q3 | $2.41M | Buy |
36,012
+3
| +0% | +$201 | ﹤0.01% | 3325 |
|
2021
Q2 | $3.84M | Buy |
36,009
+7,947
| +28% | +$848K | ﹤0.01% | 2981 |
|
2021
Q1 | $4.27M | Sell |
28,062
-12,338
| -31% | -$1.88M | ﹤0.01% | 2782 |
|
2020
Q4 | $6.76M | Buy |
40,400
+2,602
| +7% | +$435K | ﹤0.01% | 2295 |
|
2020
Q3 | $5.91M | Buy |
37,798
+8,692
| +30% | +$1.36M | ﹤0.01% | 2282 |
|
2020
Q2 | $6.1M | Buy |
29,106
+21,514
| +283% | +$4.51M | ﹤0.01% | 2226 |
|
2020
Q1 | $1.42M | Buy |
7,592
+538
| +8% | +$100K | ﹤0.01% | 2933 |
|
2019
Q4 | $1.7M | Sell |
7,054
-534
| -7% | -$129K | ﹤0.01% | 3027 |
|
2019
Q3 | $1.29M | Buy |
7,588
+1,242
| +20% | +$210K | ﹤0.01% | 3110 |
|
2019
Q2 | $1.24M | Sell |
6,346
-166
| -3% | -$32.4K | ﹤0.01% | 3064 |
|
2019
Q1 | $1.72M | Buy |
6,512
+4,711
| +262% | +$1.25M | ﹤0.01% | 3018 |
|
2018
Q4 | $360K | Buy |
+1,801
| New | +$360K | ﹤0.01% | 3538 |
|
2018
Q3 | – | Sell |
-4,373
| Closed | -$1.5M | – | 4261 |
|
2018
Q2 | $1.5M | Buy |
+4,373
| New | +$1.5M | ﹤0.01% | 3010 |
|